World Journal of Surgery

, 32:1996 | Cite as

Evidence-Based Choice of Esophageal Stent for the Palliative Management of Malignant Dysphagia

  • Danny Yakoub
  • Ramy Fahmy
  • Thanos Athanasiou
  • Afshin Alijani
  • Christopher Rao
  • Ara Darzi
  • George B. Hanna
Article

Abstract

Background

The type of stent used for the management of patients with malignant dysphagia is chosen according to subjective physician’s preference. There is no recent study available to provide updated evidence on early outcomes related to the use of different types of stents.

Methods

A literature search was performed using Embase, MEDLINE, Cochrane Library, and Google Scholar databases for comparative studies assessing different types of stents. The primary end point was stent-related mortality; secondary end points included: stent-related morbidity, successful palliation of dysphagia, and 30-day mortality. A random-effects model was used and heterogeneity was assessed.

Results

Twelve studies that included 911 patients compared metallic (46.54%) and plastic stents (53.45%), and eight studies that included 564 patients compared covered (43.26%) and uncovered metal stents (56.73%). Meta-analysis of randomized, controlled trials showed that metallic stents were associated with significantly reduced stent-related mortality (1.7% vs. 11.1% for the plastic group, odds ratio (OR), 0.2; 95% confidence interval (CI), 0.06–0.74; P = 0.02), morbidity in the form of reduced esophageal perforation (1.4% vs. 9.4% for plastic stent, OR, 0.27; 95% CI, 0.08–0.89; P = 0.03), and stent migration, yet increased rate of tumor in-growth (13% vs. 1.6% for plastic stents, OR, 4.84; 95% CI, 0.99–23.76; P = 0.05). Covered metallic stents had significantly less tumor in-growth than the uncovered and an increased migration rate. There was no significant difference between metallic and plastic stents in terms of any other stent-related morbidity and 30-day mortality.

Conclusion

Self-expanding metallic stents are superior to plastic stents in terms of stent insertion-related mortality, morbidity, and quality of palliation. The uncovered variety is disadvantaged by high rate of tumor in-growth; adequately designed randomized, controlled trials need to examine outcomes and cost-effectiveness of covered versus uncovered metallic stents.

References

  1. 1.
    Siersema PD, Hop WC, van BM, van Tilburg AJ, Bac DJ, Homs MY, Kuipers EJ (2001) A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 54:145–153PubMedGoogle Scholar
  2. 2.
    Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N (1993) A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329:1302–1307PubMedCrossRefGoogle Scholar
  3. 3.
    Baron TH (2001) A practical guide for choosing an expandable metal stent for GI malignancies: is a stent by any other name still a stent? Gastrointest Endosc 54:269–272PubMedGoogle Scholar
  4. 4.
    Allum WH, Griffin SM, Watson A, Colin-Jones D (2002) Guidelines for the management of oesophageal and gastric cancer. Gut 50(Suppl 5):v1–v23PubMedGoogle Scholar
  5. 5.
    Shenfine J, McNamee P, Steen N, Bond J, Griffin SM (2005) A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 9:iii1–iii121Google Scholar
  6. 6.
    Ferguson R, Atkinson M (1977) Dysphagia. Br Med J 1:714PubMedGoogle Scholar
  7. 7.
    Clarke M, Oxman A (eds) (2001) Cochrane reviewer’s handbook 4.1.3 [updated June 2001]. In: The Cochrane Library, Issue 3: Oxford: Update SoftwareGoogle Scholar
  8. 8.
    Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (2000) Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: the QUOROM Statement. Onkologie 23:597–602PubMedCrossRefGoogle Scholar
  9. 9.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  10. 10.
    Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedGoogle Scholar
  11. 11.
    Egger M, Smith GD (1995) Misleading meta-analysis. BMJ 311:753–754PubMedGoogle Scholar
  12. 12.
    Siersema PD, Hop WC, Dees J, Tilanus HW, van BM (1998) Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 47:113–120PubMedCrossRefGoogle Scholar
  13. 13.
    Segalin A, Bonavina L, Carazzone A, Ceriani C, Peracchia A (1997) Improving results of esophageal stenting: a study on 160 consecutive unselected patients. Endoscopy 29:701–709PubMedGoogle Scholar
  14. 14.
    De Palma GD, Di ME, Romano G, Fimmano A, Rondinone G, Catanzano C (1996) Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 43:478–482PubMedGoogle Scholar
  15. 15.
    Mosca F, Consoli A, Stracqualursi A, Persi A, Portale TR (2003) Comparative retrospective study on the use of plastic prostheses and self-expanding metal stents in the palliative treatment of malignant strictures of the esophagus and cardia. Dis Esophagus 16:119–125PubMedCrossRefGoogle Scholar
  16. 16.
    Birch JF, White SA, Berry DP, Veitch PS (1998) A cost-benefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors. Dis Esophagus 11:172–176PubMedGoogle Scholar
  17. 17.
    Taal BG, Kooyman WM, Boot H (1998) Expandable stents compared to conventional plastic endoprostheses in malignant oesophageal obstruction, especially in cardiac cancer and fistulas: the experience of the Netherlands Cancer Institute. Eur J Gastroenterol Hepatol 10:745–752PubMedCrossRefGoogle Scholar
  18. 18.
    Davies N, Thomas HG, Eyre-Brook IA (1998) Palliation of dysphagia from inoperable oesophageal carcinoma using Atkinson tubes or self-expanding metal stents. Ann R Coll Surg Engl 80:394–397PubMedGoogle Scholar
  19. 19.
    Sanyika C, Corr P, Haffejee A (1999) Palliative treatment of oesophageal carcinoma–efficacy of plastic versus self-expandable stents. S Afr Med J 89:640–643PubMedGoogle Scholar
  20. 20.
    Roseveare CD, Patel P, Simmonds N, Goggin PM, Kimble J, Shepherd HA (1998) Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol 10:653–657PubMedGoogle Scholar
  21. 21.
    O’Donnell CA, Fullarton GM, Watt E, Lennon K, Murray GD, Moss JG (2002) Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 89:985–992PubMedCrossRefGoogle Scholar
  22. 22.
    Kozarek RA, Ball TJ, Brandabur JJ, Patterson DJ, Low D, Hill L, Raltz S (1996) Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 43:204–208PubMedCrossRefGoogle Scholar
  23. 23.
    De Ronde T, Martinet JP, Delos M, Jamart J, Lacrosse M, Melange M (2000) Oesophageal self expanding metal stents. Preliminary report about covered and non-covered types. Acta Gastroenterol Belg 63:331–335PubMedGoogle Scholar
  24. 24.
    Yang HS, Zhang LB, Wang TW, Zhao YS, Liu L (2005) Clinical application of metallic stents in treatment of esophageal carcinoma. World J Gastroenterol 11:451–453PubMedGoogle Scholar
  25. 25.
    Rozanes I, Poyanli A, Acunas B (2002) Palliative treatment of inoperable malignant esophageal strictures with metal stents: one center’s experience with four different stents. Eur J Radiol 43:196–203PubMedCrossRefGoogle Scholar
  26. 26.
    Ell C, Hochberger J, May A, Fleig WE, Hahn EG (1994) Coated and uncoated self-expanding metal stents for malignant stenosis in the upper GI tract: preliminary clinical experiences with Wallstents. Am J Gastroenterol 89:1496–1500PubMedGoogle Scholar
  27. 27.
    Saranovic D, Djuric-Stefanovic A, Ivanovic A, Masulovic D, Pesko P (2005) Fluoroscopically guided insertion of self-expandable metal esophageal stents for palliative treatment of patients with malignant stenosis of esophagus and cardia: comparison of uncovered and covered stent types. Dis Esophagus 18:230–238PubMedCrossRefGoogle Scholar
  28. 28.
    Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, Zuccaro G, Bosco JJ, Jones WF (2001) A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96:1791–1796PubMedCrossRefGoogle Scholar
  29. 29.
    Hills KS, Chopra KB, Pal A, Westaby D (1998) Self-expanding metal oesophageal endoprostheses, covered and uncovered: a review of 30 cases. Eur J Gastroenterol Hepatol 10:371–374PubMedCrossRefGoogle Scholar
  30. 30.
    May A, Hahn EG, Ell C (1996) Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin Gastroenterol 22:261–266PubMedCrossRefGoogle Scholar
  31. 31.
    Szentpali K, Palotas A, Lazar G, Paszt A, Balogh A (2004) Endoscopic intubation with conventional plastic stents: a safe and cost-effective palliation for inoperable esophageal cancer. Dysphagia 19:22–27PubMedCrossRefGoogle Scholar
  32. 32.
    Ioannidis JP, Cappelleri JC, Lau J (1998) Issues in comparisons between meta-analyses and large trials. JAMA 279:1089–1093PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2008

Authors and Affiliations

  • Danny Yakoub
    • 1
  • Ramy Fahmy
    • 1
  • Thanos Athanasiou
    • 1
  • Afshin Alijani
    • 1
  • Christopher Rao
    • 1
  • Ara Darzi
    • 1
  • George B. Hanna
    • 1
    • 2
  1. 1.Imperial College of Science, Technology and Medicine, Department of Bio-surgery and Surgical TechnologySt Mary’s HospitalLondonUK
  2. 2.Department of Surgical Oncology and TechnologySt Mary’s HospitalLondonUK

Personalised recommendations